42 related articles for article (PubMed ID: 35220866)
1. Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis.
Amonkar MM; Abderhalden LA; Fox GE; Frederickson AM; Grira T; Gozman A; Malhotra U; Malbecq W; Akers KG
Future Oncol; 2024 Apr; 20(13):863-876. PubMed ID: 38353044
[No Abstract] [Full Text] [Related]
2. Adjuvant therapy in biliary tract cancers: oral fluoropyrimidine as a beginning.
Chiang NJ; Chen LT
Lancet; 2023 Jan; 401(10372):170-171. PubMed ID: 36681404
[No Abstract] [Full Text] [Related]
3. New and emerging treatment options for biliary tract cancer.
Noel MS; Hezel AF
Onco Targets Ther; 2013 Oct; 6():1545-52. PubMed ID: 24204165
[TBL] [Abstract][Full Text] [Related]
4. Response letter to "Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers".
Ichimura T
J Oncol Pharm Pract; 2023 Mar; ():10781552231165235. PubMed ID: 36927219
[No Abstract] [Full Text] [Related]
5. Response to response to letter entitled: Re: Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France.
Guennebaud B; Rivoire A
Eur J Cancer; 2023 Nov; 193():113279. PubMed ID: 37678104
[No Abstract] [Full Text] [Related]
6. Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review.
Wang Y; Wen N; Wang S; Nie G; Tian Y; Lu J; Li B
BMC Cancer; 2023 Apr; 23(1):378. PubMed ID: 37098481
[TBL] [Abstract][Full Text] [Related]
7. Current Trends in Inpatient Care and In-Hospital Mortality of Cholangiocarcinoma in Germany: A Systematic Analysis between 2010 and 2019.
Roderburg C; Essing T; Kehmann L; Krieg S; Labuhn S; Kandler J; Luedde T; Loosen SH
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011031
[TBL] [Abstract][Full Text] [Related]
8. Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.
Rizzo A; Ricci AD; Tober N; Nigro MC; Mosca M; Palloni A; Abbati F; Frega G; DE Lorenzo S; Tavolari S; Brandi G
Anticancer Res; 2020 Jun; 40(6):3013-3030. PubMed ID: 32487595
[TBL] [Abstract][Full Text] [Related]
9. Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY.
Rizzo A; Cusmai A; Giovannelli F; Acquafredda S; Rinaldi L; Misino A; Palmiotti G
Expert Rev Gastroenterol Hepatol; 2022 Mar; 16(3):273-278. PubMed ID: 35220866
[TBL] [Abstract][Full Text] [Related]
10. Combination versus mono-therapy as salvage treatment for advanced biliary tract cancer: A comprehensive meta-analysis of published data.
Ying J; Chen J
Crit Rev Oncol Hematol; 2019 Jul; 139():134-142. PubMed ID: 30979533
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
Kim BJ; Yoo C; Kim KP; Hyung J; Park SJ; Ryoo BY; Chang HM
Br J Cancer; 2017 Feb; 116(5):561-567. PubMed ID: 28081540
[TBL] [Abstract][Full Text] [Related]
12. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
Guo X; Zhao F; Ma X; Shen G; Ren D; Zheng F; Du F; Wang Z; Ahmad R; Yuan X; Zhao J; Zhao J
BMC Cancer; 2019 Nov; 19(1):1125. PubMed ID: 31747911
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis.
Jiang Q; Huang J; Zhang B; Li X; Chen X; Cui B; Li S; Guo G
Front Immunol; 2022; 13():801909. PubMed ID: 35309350
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer.
Ulusakarya A; Karaboué A; Ciacio O; Pittau G; Haydar M; Biondani P; Gumus Y; Chebib A; Almohamad W; Innominato PF
BMC Cancer; 2020 Jun; 20(1):515. PubMed ID: 32493242
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
